Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis

Citation
A. Zwijsen et al., Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis, DEV DYNAM, 218(4), 2000, pp. 663-670
Citations number
31
Categorie Soggetti
Cell & Developmental Biology
Journal title
DEVELOPMENTAL DYNAMICS
ISSN journal
10588388 → ACNP
Volume
218
Issue
4
Year of publication
2000
Pages
663 - 670
Database
ISI
SICI code
1058-8388(200008)218:4<663:EOTISI>2.0.ZU;2-G
Abstract
SMAD proteins are downstream targets of serine/threonine kinase receptors o f the transforming growth factor beta (TGF beta) superfamily, Ligands activ ating these receptors regulate cell growth, differentiation and development in many tissues of various organisms. In mammals eight different Smad gene s are known, each with different roles in mediating signalling between plas ma membrane and nucleus, Smad6 and Smad7 are inhibitors of TGF beta family signalling, They are both expressed in human adult vascular endothelial cel ls, particularly after these cells have been subjected to shear stress (Top per et al, [1997] Proc Natl Acad Sci USA 94: 9314-9319), Here we show by re verse transcriptase polymerase chain reaction and in situ hybridization tha t Smad7 mRNA is highly expressed in the developing vascular system of the m ouse embryo but is also detectable much earlier in preimplantation embryos and during gastrulation, We also demonstrate by transient transgenesis that overexpression of Smad7 in mouse zygotes inhibits development beyond the 2 -cell stage, This confirms earlier conclusions of similar, but complementar y, experiments using a dominant negative type II TGF beta receptor demonstr ating that TGF beta signalling is required for normal preimplantation devel opment, (C) 2000 Wiley-Liss, Inc.